Evolutionary Dynamics of Drug-Resistant Mycobacterium Tuberculosis

Drug-resistant Mycobacterium tuberculosis emerges through spontaneous chromosomal mutations in key genes such as rpoB and katG, which confer resistance to frontline drugs but often impair bacterial growth or virulence. This fitness cost is frequently offset by secondary, compensatory mutations that refine essential processes—such as transcription or cell-wall synthesis—thereby restoring competitive advantage. Epistatic interactions between resistance-conferring and compensatory mutations further shape the adaptive landscape, giving rise to distinct resistant lineages. Certain subpopulations, notably the Beijing lineage, combine low-cost resistance mutations with effective compensatory changes, enabling high transmission fitness and the formation of regional hotspots of multidrug-resistant tuberculosis (MDR-TB). Deciphering these evolutionary trajectories at molecular, within-host and population scales is vital to inform treatment regimens, surveillance frameworks and control strategies aimed at limiting the global spread of drug-resistant tuberculosis.

Research from Nature Portfolio

Recent studies have illuminated mechanisms governing the trade-off between resistance and fitness. One investigation used CRISPR interference to identify the transcription factor NusG as a critical determinant of the fitness cost in rifampicin-resistant strains. Mutations that weaken the NusG–RNA polymerase interface reduce excessive pausing during transcription and partially restore bacterial growth, offering a novel angle to exacerbate resistance costs through targeted therapies.

Another analysis of transmission fitness in a drug-resistance hotspot revealed lineage-specific differences. In Georgia, lineage 4 strains carrying rifampicin-resistance mutations showed reduced transmission compared with susceptible forms, whereas lineage 2 (Beijing) strains harbouring compensatory RNA polymerase mutations maintained transmission fitness equivalent to drug-susceptible strains. These findings underscore the importance of genetic background and epistatic interactions in determining the epidemic potential of MDR-TB.

Evolutionary Dynamics of Drug-Resistant Mycobacterium Tuberculosis publication trend

The graph below shows the total number of articles in evolutionary dynamics of drug-resistant mycobacterium tuberculosis across all publications each year (not limited to Nature Index journals).

Technical terms

Multidrug-resistant tuberculosis (MDR-TB): Tuberculosis caused by strains resistant to at least isoniazid and rifampicin.

Fitness cost: Reduction in replicative success or competitiveness of a resistant strain relative to its drug-susceptible ancestor.

Compensatory mutation: Genetic change that restores fitness lost through a resistance-conferring mutation.

Transmission fitness: Ability of a bacterial strain to spread between hosts in a population.

Epistasis: Interaction between distinct genetic mutations where the effect of one mutation depends on the presence of another.

Lineage 2/Beijing: A globally distributed subpopulation of M. tuberculosis associated with high drug resistance and epidemic spread.

References

1. Compensatory evolution in NusG improves fitness of drug-resistant M. tuberculosis. Nature (2024).
2. The relative transmission fitness of multidrug-resistant Mycobacterium tuberculosis in a drug resistance hotspot. Nature Communications (2023).
3. Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study. The Lancet Microbe (2023).
4. Discrepancy in the transmissibility of multidrug-resistant mycobacterium tuberculosis in urban and rural areas in China. Emerging Microbes & Infections (2023).
5. Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review. PLOS Pathogens (2024).